暂无内容
1. zhuang Jingjing , Tie Lu , Wu Dalei and Liu Qian. Current strategies and progress for targeting the “undruggable” transcription factors. Acta Pharmacologica Sinica, 43, 2474–2481, 2022.
2. Chen Xiaoyu , Zhao Huilin , Wang Chuandong , Hamed Mostafa , Shang Qinghong , Yang Yating , Diao Xiaotong , Sun Xiangnan , Hu Wei , Jiang Xukai , Zhang Youming , Hirsch Anna K.H , Wu Dalei and Zhuang Jingjing. Two natural compounds as potential inhibitors against the Helicobacter pylori and Acinetobacter baumannii IspD enzymes. International Journal of Antimicrobial Agents, 2024.
3. Zhuang Jingjing , Wu Dalei , Rastinejad Fraydoon and Shang Qinghong. Decoding Allosteric Control in Hypoxia-Inducible Factors. Journal of Molecular Biology, 2024.
4. Ren Xintong , Diao Xiaotong , Zhuang Jingjing and Wu Dalei. Structural Basis for the Allosteric Inhibition of Hypoxia-Inducible Factor 2 by Belzutifan. Molecular pharmacology, 2022.
5. Song Wanbin , Zhuang Jingjing , Zhang Nan , Ren Xintong , Xu Weiwei , Guo Mengqi , Diao Xiaotong , Liu Chao , Jin Jiaming , Wu Dalei and Zhang Yinan. SAR study of 1,2-benzisothiazole dioxide compounds that agonize HIF-2 stabilization and EPO production br. Bioorganic & medicinal chemistry, 77, 2023.
6. 孙向楠 , 荆林倩 , 李峰伟 , 张美娜 , 刁晓彤 , 庄静静 , Fraydoon Rastinejad and 武大雷. Structures of NPAS4-ARNT and NPAS4-ARNT2 heterodimers reveal new dimerization modalities in the bHLH-PAS transcription factor family. PNAS, 119, 2022.
1. 一种苯并异噻唑和苯并噻吩的制备方法及其医药用途
